Intermittent preventive treatment of malaria during pregnancy in central Mozambique

Bulletin of the World Health Organization

Volumn 85, Issue 11, 2007, Pages 873-879

  Brentlinger, Paula E ^a   Dgedge, Martinho ^b   Correia, Maria Ana Chadreque ^c   Rojas, Ana Judith Blanco ^c   Saúte, Francisco ^b   Gimbel Sherr, Kenneth H ^c   Stubbs, Benjamin A ^a   Mercera, Mary Anne ^a   Gloyd, Stephen ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MINISTRY OF HEALTH   (Mozambique)

^c HEALTH ALLIANCE INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FANSIDAR; HEMOGLOBIN; NEVIRAPINE; ZIDOVUDINE;

DISEASE CONTROL; DISEASE TREATMENT; MALARIA; MATERNAL HEALTH; PREGNANCY;

BED NET; BONE MARROW SUPPRESSION; ENDEMIC DISEASE; GESTATIONAL AGE; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION PREVENTION; LIVER TOXICITY; LOW BIRTH WEIGHT; MALARIA; MOZAMBIQUE; PARASITEMIA; PREGNANCY; REVIEW; SCALE UP; SKIN TOXICITY; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HEALTH POLICY; HUMANS; MALARIA; MOZAMBIQUE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROTECTIVE DEVICES; PYRIMETHAMINE; SULFADOXINE; WORLD HEALTH ORGANIZATION;

AFRICA; MOZAMBIQUE; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

EID: 36049048938     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.06.033381     Document Type: Review

References (23)

1. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007;7:93-104.
2. ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, van Eijk AM, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 2004;71:41-54.
3. A strategic framework for malaria prevention and control during pregnancy in the African Region. Brazzaville: WHO Regional Office for Africa; 2004.
4. Menéndez C, D'Alessandro U, ter Kuile F. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis 2007;7:126-35.
5. Mapeamento de vulnerabilidade. Maputo: Ministério de Plano e Finanças; 2002.
6. A statistical profile of disparities in Mozambique: an overview of the situation of children and women based on findings from the 2003 Demographic and Health Survey. Maputo: UNICEF; 2005.
7. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998;59:813-22.
8. Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 2001;358:1066-7.
9. Kobbe R, Marks F, May J, Meyer C. Editorial: Antifolates in prevention of HIV-associated opportunistic infections and in intermittent preventive treatment of malaria in Africa. Trop Med Int Health 2005;10:293-4.
10. Brentlinger PE, Montoya P, Blanco Rojas AJ, Correia MA, Dgedge M, Saúte F, et al. Prevalence and predictors of maternal peripheral malaria parasitemia in central Mozambique. Am J Trop Med Hyg 2007;77:228-34.
11. Rogerson S, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux M. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg 2000;94:549-53.
12. van Eijk A, Ayisi J, ter Kuile F, Slutsker L, Otieno J, Misora A, et al. Implementation of intermittent preventive treatment with sulphadoxine- pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya. Trop Med Int Health 2004;9:630-7.
13. Barat L, Palmer N, Basu S, Worrall E, Hanson K, Mills A. Do malaria control interventions reach the poor? A view through the equity lens. Am J Trop Med Hyg 2004;71:174-8.
14. Assessment of MIPESA country experiences in the adoption and implementation of malaria in pregnancy policies, including best practices and lessons learned. Kampala: Malaria in Pregnancy East and Southern Africa (MIPESA) Coalition; 2006.
15. Worrall E, Morel C, Yeung S, Borghi J, Webster J, Hill J, et al. The economics of malaria in pregnancy: a review of the evidence and research priorities. Lancet Infect Dis 2007;7:156-68.
16. Roll Back Malaria. Sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria during pregnancy in areas of moderate to high-level SP resistance. Geneva: WHO; 2005.
17. Van Eijk AM, Ayisi JG, Slutsker L, ter Kuile FO, Rosen DH, Otieno JA, et al. Effect of haematinic supplementation and malaria prevention on maternal anemia and malaria in western Kenya. Trop Med Int Health 2007;12:342-52.
18. Friis H. Micronutrient interventions and HIV infection: a review of current evidence. Trop Med Int Health 2006;11:1849-57.
19. Greenwood B, Alonso P, ter Kuile FO, Hill J, Steketee RW. Malaria in pregnancy: priorities for research. Lancet Infect Dis 2007;7:169-74.
20. Ward SA, Sevene EP, Hastings IM, Nosten F, McGready R. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis 2007;7:136-44.
21. Fernandes N, Figueiredo P, do Rosário VE, Cravo P. Analysis of sulphadoxine-pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant. Malar J 2007;6:35.
22. Brentlinger PE, Behrens CB, Micek MA. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa. Lancet Infect Dis 2006;6:100-11.
23. Jamisse L, Balkus J, Hitti J, Gloyd S, Manuel R, Osman N, et al. Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens. J Acquir Immune Defic Syndr 2007;44:371-6.